Drug interactions
Bendamustine + Thiotepa
Severity: Major
Bendamustine and Thiotepa: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Both are alkylating agents with marked myelosuppressive effects. Combined use can cause deeper and longer lasting cytopenias, raising the risk of infection and bleeding.
What this interaction means in plain words
Bendamustine and Thiotepa can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Bendamustine belongs to Oncology; Thiotepa belongs to Oncology.
Why it happens
Additive bone marrow suppression and DNA alkylation from two cytotoxic alkylating agents.
What to do
If combined in a planned regimen, monitor complete blood counts frequently and adjust doses or delay cycles for cytopenias; otherwise avoid.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bendamustine and Thiotepa, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Bendamustine
Other interactions of Thiotepa
- Chlorambucil + Thiotepa Major
- Clarithromycin + Thiotepa Major
- Cyclophosphamide + Thiotepa Major
- Dacarbazine + Thiotepa Major
- Deferiprone + Thiotepa Major
- Fingolimod + Thiotepa Major
Frequently asked questions
Can I take Bendamustine with Thiotepa?
MediHelp rates the interaction as major. Bendamustine and Thiotepa can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both are alkylating agents with marked myelosuppressive effects. Combined use can cause deeper and longer lasting cytopenias, raising the risk of infection and bleeding.
How serious is the interaction between Bendamustine and Thiotepa?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: If combined in a planned regimen, monitor complete blood counts frequently and adjust doses or delay cycles for cytopenias; otherwise avoid.
What other medicines interact with Bendamustine?
MediHelp also lists interactions of Bendamustine with, for example, Axicabtagene ciloleucel, Brexucabtagene autoleucel, Chlorambucil. The full list is on the Bendamustine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
